Insulin resistance and obesity are intricately related health concerns, each increasing at rapid rates, affecting at least 75% of United States adults. The intertwining of insulin resistance and obesity increases the risk of developing other metabolic disorders, like type 2 diabetes, cardiovascular disease, hypertension, hyperlipidemia, and non-alcoholic fatty liver disease.
Appropriately addressing insulin resistance and obesity requires a multidisciplinary approach that includes lifestyle modifications focused on nutrition and physical activity. In other cases, pharmacotherapy and even bariatric surgery may play a role in treatment. Understanding the intricate relationships between insulin resistance and obesity allows us to focus on lifestyle interventions that can simultaneously treat both conditions.
[signup]
What is Insulin Resistance?
Insulin has two main functions, one of which is acting as a hormone to reduce blood glucose levels and the second of which is to act as a signaling molecule for cells in virtually every organ of the body. Insulin resistance represents a metabolic disruption occurring when cells of the body fail to respond to insulin stimulation, both as a signaling molecule and as a hormone to lower glucose levels.
To understand insulin resistance, first, we need to understand the physiology of insulin. It is released by the pancreatic beta cells in response to a rise in blood glucose, which occurs with carbohydrate metabolism in a healthy patient. When a patient eats carbohydrates and the body metabolizes them, blood glucose rises, signaling the pancreas to release insulin. Insulin then helps restore blood glucose back to appropriate levels by telling cells how to use the glucose - to shuttle it to various organs as energy or to store the glucose as fat (adipose tissue.)
However, insulin resistance occurs when this process is blunted, when the blood glucose remains consistently elevated, or when the pancreas is constantly stimulated to release insulin. Insulin resistance can also occur when cellular receptors are less responsive to insulin stimulation.
The Biology of Obesity and Its Impact on Insulin Sensitivity
Both type 2 diabetes and obesity are associated with insulin resistance. Insulin resistance is a precursor to type 2 diabetes, an early step in the process. A patient can have insulin resistance and not type 2 diabetes, but one cannot have type 2 diabetes and not insulin resistance. Obesity, however, is also associated with insulin resistance, as excess accumulation of adipose tissue is a significant risk factor for developing insulin resistance.
Adipose tissue (particularly visceral or abdominal fat) secretes pro-inflammatory cytokines and adipokines, which are known to disrupt insulin signaling pathways, thus promoting insulin resistance. In addition, elevated levels of free fatty acids in obesity further exacerbate insulin resistance by interfering with insulin action in peripheral tissues.
Finally, insulin is a pro-inflammatory hormone, and obesity is a pro-inflammatory state, each associated with energy storage rather than energy burning, representing a continuous cycle of weight gain and metabolic dysfunction.
Clinical Consequences of Insulin Resistance and Obesity
The combination of insulin resistance and obesity causes significant health concerns, increasing the risk of developing diseases of metabolic dysfunction and cardiovascular disease. Not only is insulin resistance a precursor to type 2 diabetes mellitus, but obesity, of course, predisposes to insulin resistance. In the presence of obesity, if insulin resistance develops, the risk is that chronic hyperinsulinemia may overwork the pancreatic beta cells, causing impaired glucose tolerance and then type 2 diabetes.
Insulin resistance and obesity both increase the risk of atherosclerosis and endothelial dysfunction, raising the risk of hyperlipidemia, coronary artery disease, stroke, and peripheral artery disease. Obesity also causes systemic inflammation, which independently increases cardiovascular risk.
Insulin resistance promotes the storage of glucose as fat in the liver and the formation of triglycerides, leading to the development of non-alcoholic fatty liver disease (NAFLD). Obesity accelerates the progression of NAFLD, increasing the risk of liver inflammation, fibrosis, and, ultimately, cirrhosis.
Both insulin resistance and obesity are core components of metabolic syndrome, which is a constellation of adverse metabolic conditions: central obesity, dyslipidemia, hypertension, and impaired glucose metabolism. Metabolic syndrome is a state of chronic inflammation, thus driving increased risks of both cardiovascular disease and type 2 diabetes.
Identifying Insulin Resistance in Obese Patients
Insulin resistance develops gradually and exists on a spectrum. Therefore, diagnosing insulin resistance requires the assessment of various biomarkers related to glucose metabolism.
Serum insulin levels should be tested both in a fasting state and after eating a carbohydrate-containing meal.. When insulin resistance startsto develop, postprandial insulin levels will rise first as the pancreas secretes more insulin in response to carbohydrate metabolism, followed by elevated fasting levels to continue tolower blood glucose.
A fasting blood glucose and an oral glucose tolerance test should be performed alongside insulin levels as an integrated test like HOMA-IR to understand how insulin levels correspond with serum glucose levels. Postprandial glucose levels will rise first, as the body becomes less able to minimize the rise in blood glucose after eating when insulin resistance is present. Next, as the body becomes less and less able to maintain normal glucose levels, fasting blood glucose levels will also rise. Elevated fasting glucose levels (>100 mg/dL) indicate impaired fasting glucose and may suggest underlying insulin resistance when correlated with insulin levels.
The hemoglobin A1c (HbA1c) test measures the average blood glucose levels over the life of the hemoglobin molecule, which is generally about three months. Higher HbA1c levels (>5.7%) are a later indicator of impaired glucose metabolism and indicate that insulin resistance is not a new occurrence.
Early identification of insulin resistance in obese individuals is important for several reasons. Early detection allows early intervention, which may help delay the onset of type 2 diabetes, cardiovascular disease, and other metabolic dysregulations associated with insulin resistance and obesity. Identifying insulin resistance early also allows for lifestyle interventions first, including dietary changes, establishing regular physical exercise, and effectively managing weight, all of which help improve insulin sensitivity to slow either the onset or progression of metabolic dysfunction.
[signup]
Lifestyle Interventions for Managing Insulin Resistance and Obesity
Lifestyle interventions play an integral role in managing insulin resistance and obesity, providing effective strategies for improving metabolic health and reducing the risk of associated complications. Dietary modifications, including focusing on a diet mainly of whole grains, fruits, vegetables, lean proteins, and healthy fats while minimizing refined sugars and processed foods, help regulate blood glucose and promote healthy weight maintenance.
Balancing energy intake and macronutrient composition is central to good dietary strategies. Regular physical activity, including cardiovascular exercise and strength or resistance training, enhances insulin sensitivity, increases energy expenditure to promote a healthy weight, and improves overall cardiovascular health.
Dietary Strategies to Improve Insulin Sensitivity
Diet is one of the most significant drivers of insulin sensitivity. A healthy diet should prioritize whole, natural , nutrient-dense foods while also minimizing the consumption of refined carbohydrates, added sugars, and other processed foods. Opt for healthy unsaturated fats found in nuts, seeds, avocados, and fatty fish to enhance insulin sensitivity. Focus on omega-3 fatty acids, which have been shown to reduce inflammation and improve the effects of inflammation. Increasing the intake of high-fiber foods like fruits, vegetables, legumes, and whole grains can help minimize blood sugar spikes, decreasing insulin release and thus promoting insulin sensitivity.
The Role of Physical Activity
Regular physical activity, including cardiovascular exercise and strength training, is vital in improving insulin sensitivity and maintaining an optimal weight. Cardiovascular exercise, like fast walking, jogging, running, cycling, and swimming, enhances insulin sensitivity by increasing glucose uptake and utilization in skeletal muscles. This reduces blood glucose levels and improves insulin resistance. Cardiovascular exercise is known to help promote a healthy weight by increasing energy expenditure and promoting fat oxidation.
Strength training, including both weight lifting and bodyweight exercise, has also been shown to improve insulin sensitivity by increasing muscle mass and increasing glucose uptake into muscles. Strength training is known to help increase and preserve lean body mass, supporting long-term weight management by increasing resting energy expenditure. Combining both cardiovascular exercise and strength training improves insulin sensitivity, promotes weight loss, and helps maintain metabolic health.
Medical Treatments for Insulin Resistance and Obesity
When lifestyle modifications do not sufficiently improve insulin resistance or obesity, several medical treatments and surgical interventions can be utilized, such as personalized health plans based on individual health conditions. Metformin is a first-line medication for type 2 diabetes, often prescribed to improve insulin sensitivity and reduce hepatic gluconeogenesis.
Metformin also helps manage a healthy weight by reducing appetite and helping with marginal weight loss. Glucagon-like-peptide-1 receptor agonists (GLP-1 RA), including liraglutide and semaglutide, improve insulin secretion and slow gastric emptying, which leads to better glycemic control and clinically significant weight loss.
In cases of severe obesity or when lifestyle interventions and pharmacotherapy are insufficient, bariatric surgery may provide a viable option for long-term weight loss success and improved metabolic health. Bariatric surgical techniques like sleeve gastrectomy and Roux-en-Y gastric bypass can lead to substantial weight loss and even the resolution of conditions like obesity, type 2 diabetes, hypertension, and dyslipidemia. Bariatric surgery and the loss of notable amounts of excess adipose tissue lead to hormonal changes that improve insulin sensitivity, leading to sustainable weight loss and metabolic health benefits.
[signup]
Preventing Insulin Resistance Through Obesity Management
Preventing insulin resistance starts with both preventing obesity and optimizing healthy lifestyles, including optimizing both nutrition and physical activity. This requires a multifaceted approach that focuses on public health interventions, patient education, and implementing healthy individual lifestyle choices. Public health initiatives promoting healthy eating habits, physical activity, and changes in our food supply will create supportive environments conducive to maintaining a healthy weight and optimal metabolic health.
Education is vital to increase awareness around the risks of obesity and insulin resistance, empowering individuals to make their own informed lifestyle choices. Providing education on healthy eating, controlling portions, and the grave importance of regular physical exercise is a starting point for initial behavior change and adherence.
Individual patients should be empowered to eat a balanced diet of whole,natural, nutrient-dense foods, minimizing their intake of processed foods, added sugars, and trans fats. This has been shown to help prevent obesity and combat insulin resistance. Individual patients are also responsible for adhering to regular physical exercise, both cardiovascular exercise and strength training, for significant metabolic benefits.
Lastly, the importance of stress management, optimal sleep, and ensuring mental well-being cannot be ignored, as it is integral to preventing obesity and insulin resistance.
By understanding insulin resistance and the impact of obesity, the treatment of both obesity and insulin resistance should exist together in patients who are at high risk of metabolic dysfunction. Early identification and implementation of lifestyle interventions and using medical treatments only if lifestyle interventions fail is the first step. The addition of GLP-1 RA and/or metformin, plus the utility of bariatric surgery, should be merely adjunctive therapy to a healthy diet and exercise only when necessary. Lastly, public health policies and individual responsibilities should be in place to promote healthier lifestyles.
%201.svg){kind=logo}
Ready to become a world class gut health expert? Join Jeannie Gorman, MS, CCN, for a 
